Quantitative ligand-binding assays (immunoassays), qualitative immunogenicity assessments, cell-based assays for neutralizing antibodies and biomarker assays in combination with toxicokinetics and clinical pharmacokinetics for large molecules.
Intertek has extensive experience in the development, validation and sample analysis of quantitative and qualitative GLP and Non-GLP immunoassays in support of clinical and preclinical studies for the measurement of therapeutic drugs, synthetic peptides, humanized monoclonal antibodies, chimerics, conjugated drugs, various growth factors, hormones, cytokines and biomarkers.
Industry-leading scientific expertise includes developing and validating proprietary assays, implementing and validating existing methods, optimizing methods then validating, and validating existing immunoassay kits (ELISA and ECL platforms). The laboratory is FDA inspected and GLP-compliant.
This GLP laboratory is recognized as one of the leading immunochemistry laboratories in the world. Founded in 1999, the research facility is located in San Diego, California. The Senior Laboratory Director is Dominique Gouty.
- Biomarker Assays and Validation
- Cell-Based Neutralization Assays
- Immunogenicity Assays
- Ligand-Binding Assays
Related Services for Macromolecules
Related Services for Small Molecules
Request more information to see how Intertek can help your organization with Immunochemistry Services.